J.P. Morgan Private Wealth Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$217K	Buy	30,603 +1,309	+4%	+$9.27K	﹤0.01%	1607
2023 Q2	$206K	Buy	29,294 +17,457	+147%	+$123K	﹤0.01%	1380
2023 Q1	$98.7K	Buy	+11,837	New	+$98.7K	﹤0.01%	1899